JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 36 No. 2 267-269
© 1995 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scalzetti, E. M.
Right arrow Articles by Gagne, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scalzetti, E. M.
Right arrow Articles by Gagne, G. M.

The Transition from Technegas to Pertechnegas

Ernest M. Scalzetti and George M. Gagne

Department of Radiology, SUNY Health Science Center at Syracuse, Syracuse, New York

Correspondence: For correspondence or reprints contact: Dr. Ernest M. Scalzetti, MD, Dept. of Radiology, SUNY Health Science Center at Syracuse, 750 East Adams St, Syracuse, NY 13210.

ABSTRACT

We set out to determine the oxygen concentration of the argon-oxygen mixture in the technegas generator where technegas-like behavior changes to pertechnegas-like behavior which allows [99mTc]pertechnetate to enter the solution. Methods: We prepared radioaerosols analogous to technegas and pertechnegas, with oxygen concentrations between 0% and 5%. They then were examined by thin-layer chromatography using saline as a solvent to measure the amount of [99mTc]pertechnetate moving with the solvent front as a function of oxygen concentration. Results: The amount of mobile pertechnetate markedly increased when the radioaerosols were created in an atmosphere containing between 0.1% and 0.2% oxygen. The transition from technegas-like to pertechnegas-like behavior occurs when the oxygen-argon gas mixture contains lower concentrations of oxygen than those used in the preparation of pertechnegas. Conclusion: Argon intended for the preparation of technegas should contain no more than 0.1% oxygen.

Key Words: technegas • pertechnegas • technetium-99m-pertechnetate • argon • radioaerosol




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
J. Petersson, A. Sanchez-Crespo, S. A. Larsson, and M. Mure
Physiological imaging of the lung: single-photon-emission computed tomography (SPECT)
J Appl Physiol, January 1, 2007; 102(1): 468 - 476.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. Wiebert, A. Sanchez-Crespo, J. Seitz, R. Falk, K. Philipson, W. G. Kreyling, W. Moller, K. Sommerer, S. Larsson, and M. Svartengren
Negligible clearance of ultrafine particles retained in healthy and affected human lungs
Eur. Respir. J., August 1, 2006; 28(2): 286 - 290.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
N. L. Mills, N. Amin, S. D. Robinson, A. Anand, J. Davies, D. Patel, J. M. de la Fuente, F. R. Cassee, N. A. Boon, W. MacNee, et al.
Do Inhaled Carbon Nanoparticles Translocate Directly into the Circulation in Humans?
Am. J. Respir. Crit. Care Med., February 15, 2006; 173(4): 426 - 431.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. S. Brown, K. L. Zeman, and W. D. Bennett
Ultrafine Particle Deposition and Clearance in the Healthy and Obstructed Lung
Am. J. Respir. Crit. Care Med., November 1, 2002; 166(9): 1240 - 1247.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M.J. Thomeer, B. Dehaes, L. Mortelmans, and M. Demedts
Pertechnegas lung clearance in different forms of interstitial lung disease
Eur. Respir. J., January 1, 2002; 19(1): 31 - 36.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1995 by the Society of Nuclear Medicine.